BMC Infectious Diseases (Nov 2022)

Prevalence and correlates of substance use and associations with HIV-related outcomes among trans women in the San Francisco Bay Area

  • Elaine Hsiang,
  • Akua Gyamerah,
  • Glenda Baguso,
  • Jennifer Jain,
  • Willi McFarland,
  • Erin C. Wilson,
  • Glenn-Milo Santos

DOI
https://doi.org/10.1186/s12879-022-07868-4
Journal volume & issue
Vol. 22, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Background Trans women face tremendous social inequities as well as disproportionate rates of HIV and substance use, yet disaggregated substance use data specific to trans women remain limited. Methods We conducted a secondary analysis of baseline data from the Trans*National Study (2016–2017) surveying trans women in the San Francisco Bay Area (n = 629). Multivariable logistic regression was used to analyze socio-demographic and environmental correlates of substance use, and bivariate associations between substance use and HIV-associated outcomes are presented alongside prevalence data. Results Over half (52.9%) reported using substances in the prior year, most frequently marijuana, methamphetamine, and crack/cocaine. Those with unmet gender-affirming health care needs, lack of insurance, or a history of experiencing racial violence, transphobic violence, adult housing instability, or extreme poverty had higher odds of substance use. Sex work and condomless anal sex were also independently associated with substance use. Conclusions Among this sample of trans women, substance use and substance use concurrent with sex were highly prevalent, and associated with a number of socioeconomic and health care needs. These findings corroborate the need for holistic and intersectional efforts to reduce substance use and HIV risk.

Keywords